“…Table 1 demonstrates that the UK early stage innovative venture market contains a range of public interventions including investor tax breaks, grants and equity funds, to address perceived early stage private equity funding gaps (where banks will not lend, North et al, 2013), particularly in the key, high risk valley of death area from proof of concept to early trading (up to 2 years). This is the so-called Macmillan gap (1931), currently thought to extend in the UK between £250k to £5m (Owen et al, 2019) and which may extend further for long horizon Cleantech R&D (BEIS, 2017). North et al (2013) highlight the importance of early stage funding complementarity to meet the financing demands of early stage ventures, suggesting that a fluent funding escalator requires effective bundling of different forms of finance, whilst Hopp (2010) recognised the value of syndicationnotably between VCs (although increasingly occurring in recent times between seed VCs, accelerators, equity crowd funders and business angels (Baldock & Mason, 2015;Owen et al, 2019) -to raise investment levels, share risks, introduce more diverse investor skills, facilitate longer distance equity investment (between some investors and ventures) and open up international markets.…”